1. Home
  2. XYLO vs TTNP Comparison

XYLO vs TTNP Comparison

Compare XYLO & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XYLO
  • TTNP
  • Stock Information
  • Founded
  • XYLO 1999
  • TTNP 1991
  • Country
  • XYLO Israel
  • TTNP United States
  • Employees
  • XYLO N/A
  • TTNP N/A
  • Industry
  • XYLO
  • TTNP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • XYLO
  • TTNP Health Care
  • Exchange
  • XYLO NYSE
  • TTNP Nasdaq
  • Market Cap
  • XYLO 3.1M
  • TTNP 3.0M
  • IPO Year
  • XYLO N/A
  • TTNP 1996
  • Fundamental
  • Price
  • XYLO $3.81
  • TTNP $3.67
  • Analyst Decision
  • XYLO
  • TTNP
  • Analyst Count
  • XYLO 0
  • TTNP 0
  • Target Price
  • XYLO N/A
  • TTNP N/A
  • AVG Volume (30 Days)
  • XYLO 9.8K
  • TTNP 25.0K
  • Earning Date
  • XYLO 09-20-2024
  • TTNP 03-31-2025
  • Dividend Yield
  • XYLO N/A
  • TTNP N/A
  • EPS Growth
  • XYLO N/A
  • TTNP N/A
  • EPS
  • XYLO N/A
  • TTNP N/A
  • Revenue
  • XYLO $57,642,000.00
  • TTNP N/A
  • Revenue This Year
  • XYLO $16.76
  • TTNP N/A
  • Revenue Next Year
  • XYLO $5.71
  • TTNP N/A
  • P/E Ratio
  • XYLO N/A
  • TTNP N/A
  • Revenue Growth
  • XYLO N/A
  • TTNP N/A
  • 52 Week Low
  • XYLO $2.70
  • TTNP $3.03
  • 52 Week High
  • XYLO $8.83
  • TTNP $14.80
  • Technical
  • Relative Strength Index (RSI)
  • XYLO 39.04
  • TTNP 50.98
  • Support Level
  • XYLO $4.08
  • TTNP $3.35
  • Resistance Level
  • XYLO $5.33
  • TTNP $4.24
  • Average True Range (ATR)
  • XYLO 0.49
  • TTNP 0.29
  • MACD
  • XYLO -0.09
  • TTNP 0.02
  • Stochastic Oscillator
  • XYLO 0.00
  • TTNP 46.73

About XYLO XYLO TECHNOLOGIES LTD

Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others.

About TTNP Titan Pharmaceuticals Inc.

Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.

Share on Social Networks: